ArticlePloS one2014

Bronchodilatory and anti-inflammatory effects of ASM-024, a nicotinic receptor ligand, developed for the treatment of asthma.

Evelyne Israël Assayag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.